Search

everythinglearnresearchcommunity

for

Search:↓

Intradermotherapy with minoxidil is as effective as topical application for treating hair loss.

Topical minoxidil is the best-supported treatment for female hair loss, but personalized plans are needed.

In Spain, dermatologists most commonly prescribe topical minoxidil and oral finasteride for male hair loss, and topical minoxidil and oral contraceptives for female hair loss. The use of oral dutasteride and oral minoxidil has significantly increased over the past three years.

Combination therapies for androgenetic alopecia work best but can have significant side effects and costs.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Tamoxifen effectively treats gynecomastia without causing impotence.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

Certain drugs that block specific enzymes can help treat prostate diseases.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

DHT stops hair regrowth in mice, similar to human hair loss.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

Adjusting minoxidil dosage may be safer than using bicalutamide for hair loss in women.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Finasteride may improve prostate cancer treatment outcomes.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Herpes zoster infection can cause permanent hair color change in the affected area.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Phyllanthus urinaria extract may help treat hair loss by blocking a hair-related enzyme.

The balance between androgen receptor and p53 is crucial for sebaceous gland differentiation.